The integration of digital tools into mental health services represents a significant leap forward in how we approach care. Indeed, recent data in 2022 suggests that when people use mental health apps, they use several apps and create their own digital toolkits by creating their own poly-digital ecosystem21. A clear benefit of digital interventions (e.g. apps and chatbots) is that they can have an adjunctive use in therapy provision, and are available 24/7 allowing clients to access support in-between face-to-face therapy sessions and seek support in less sociable hours. Figure 1b presents a similar set of digital mental health technologies showing those applications that are relatively static (e.g. a psychoeducational app) as well as those tools that are arguably more interactive and dynamic in nature (e.g. chatbots and virtual reality).
Future outlook
For instance, while during the pandemic the perceived added value of DMH tools was compared to no care – and hence often evaluated as better than nothing – with voluntary use practitioners will take their former (face-to-face) care as their point of comparison, which is likely to alter their estimation of perceived value. However, the fact that such DMH tool use was largely forced upon the healthcare professional as the only viable option for continued care does raise the question to what extent such experiences generalize to situations of voluntary use. Implementation of blended care also implies getting accustomed to a different workflow and distribution of time, for example, scheduling time spent on providing feedback on online homework assignments. As blended forms with a variable mix of face-to-face and online components are likely to become the default, this also requires practitioners to become proficient in determining when to apply face-to-face or online elements, and how to involve clients in the decision process (38). While the gains of this ad hoc process are certainly applicable for regular use, sustainable implementation of DMH does come with additional requirements for both the tools as well as the necessary skills.
- The rapid growth of these resources requires a carefully planned response by treatment and prevention programs targeting behavioral health.
- Looking ahead, innovation in engagement strategies and implementation science will play pivotal roles in advancing the next generation of digital tools.
- Because many AI‐powered tools and mobile apps have high initial engagement but low long‐term adherence, more interactive, tailored, and flexible intervention approaches may be needed to retain users.
- As digital mental health solutions get increasingly sophisticated, what is their role alongside traditional therapeutic approaches?
- The emerging field of HCI is important for the efficacy of a hybrid model of care, especially for psychological screening and tracking with real-time automation and machine learning .
- The sense of excitement for integrating digital mental health with the delivery of mental health services to meet the increased demand is countered by the need for a more compelling evidence base for successful implementation and integration.
Research shows that digital treatments for mental health improve well‐being, stress, anxiety, and depression. By demonstrating that more physical activity and better sleep reduced sadness and anxiety, wearable technology showed its potential in mental health therapy. User engagement and retention remain key barriers to digital mental health therapy adoption. This study emphasizes the necessity for laws that ensure digital mental health services are provided to everybody, particularly in developing nations.
Literature Screening and Data Extraction
Healthcare providers must keep the patient and their concerns at the centre of care (52). Wearables offer real-time monitoring and feedback, aiding individuals in the maintenance of positive health behaviors through personalised insights and continuous engagement. Social media can disseminate health information widely, fostering awareness and contemplation.
Self-Directed, Web-Based, and Computer-Based Therapeutic Tools
The asynchronous nature accommodates the demanding schedules that characterise modern life, removing yet another barrier to consistent care. The anonymity inherent in many digital platforms reduces stigma’s grip, encouraging earlier intervention before challenges compound. Stigma continues preventing individuals from seeking support through conventional channels, and waiting lists delay intervention precisely when timely support would prove most transformative. The landscape now encompasses therapy and counselling platforms like Talkspace and BetterHelp connecting individuals with licensed professionals across continents and time zones. As we navigate 2026, we’re witnessing a transformative moment where mobile technology transcends its role as mere tool, becoming instead a compassionate companion in the journey towards mental wellbeing. The intersection of mental wellness and digital innovation represents one of our generation’s most profound opportunities for collective healing.
Additional challenges include problems with reproducibility in diverse samples; it is not yet clear that the digital biomarkers collected in 20-year-olds who use their smartphones more than 4 hr/day will generalize to 70-year-olds who use their phones much less frequently. Sleep and activity are relatively straightforward, but digital phenotyping also includes digital biomarkers extracted from subtle aspects of smartphone use, such as keystroke and scrolling patterns. This approach requires that the phone delivers valid, actionable signals and that those signals be transmitted to a clinician who can respond. In clinical trials, digital phenotyping is being used to detect early changes in depression, schizophrenia, and posttraumatic stress disorder (PTSD), validated by gold-standard clinical ratings. It may not be surprising that severe depression or mania would be reflected in activity or sleep data or that psychosis would influence human–computer interaction. Even when validated assessment tools are used, clinicians are limited to episodic self-report measures collected in a clinic, which are subject to recall bias.
Uptake and adherence might be improved by providing support by practitioners, which might require further time, resources and training. Even technologies recommended by NICE have limited evidence, for example the most recent evaluation of Stressbusters did not find a positive effect at 12 months (Wright 2020). Many of the studies available are small and primarily undertaken by the programme developers. There is a need for more technologies that have been co-developed and evaluated rigorously according to research frameworks (e.g. Craig 2008). Although the studies are promising, there are several https://www.ihs.gov/california/index.cfm/offices/oph/bh/resources/helpful-organizations/ key challenges in this field, including methodological limitations (Hollis 2017; Grist 2019).
